EFFICACY OF INTERVENTIONS TO PROMOTE RESEARCH CAREERS
RELEASE DATE: August 24, 2004
RFA Number: RFA-GM-05-009 (Reissued as RFA-GM-07-005)
EXPIRATION DATE: November 16, 2004
Department of Health and Human Services (DHHS)
PARTICIPATING ORGANIZATION:
National Institutes of Health (NIH)
(http://www.nih.gov/)
COMPONENTS OF PARTICIPATING ORGANIZATION:
National Institute of General Medical Sciences (NIGMS)
(http://www.nigms.nih.gov/)
National Institute of Child Health and Human Development (NICHD)
(http://www.nichd.nih.gov/)
CATALOG OF FEDERAL DOMESTIC ASSISTANCE NUMBER(S): 93.859, 93.864
LETTER OF INTENT RECEIPT DATE: October 18, 2004
APPLICATION RECEIPT DATE: November 15, 2004
THIS RFA CONTAINS THE FOLLOWING INFORMATION
o Purpose of this RFA
o Research Objectives
o Mechanism of Support
o Funds Available
o Eligible Institutions
o Individuals Eligible to Become Principal Investigators
o Where to Send Inquiries
o Letter of Intent
o Submitting an Application
o Peer Review Process
o Review Criteria
o Receipt and Review Schedule
o Award Criteria
o Required Federal Citations
PURPOSE OF THIS RFA
The goal of this RFA is to support research that will test assumptions
regarding the effectiveness of interventions that are intended to increase
interest, motivation and preparedness for careers in biomedical research,
with a particular interest in those interventions specifically designed to
increase the number of underrepresented minority students entering careers in
biomedical and behavioral research. Since it is likely that comparable
interventions are applicable to students universally, the proposed research
need not be restricted to underrepresented minority students. Indeed,
comparative research may well be particularly illuminating and is, therefore,
encouraged.
RESEARCH OBJECTIVES
The National Institutes of Health (NIH) recognizes that there is a
significant under-representation of minority scientists engaged in biomedical
and behavioral research in the U.S. Consequently, over the past 30 years the
NIGMS, other institutes of the NIH, other agencies of the federal government
and private foundations have instituted a variety of programs designed to
redress this disparity. To accomplish the goal, the programs supported three
main types of objectives: a) increasing the participant pool generally by
stimulating students' interest at multiple stages, starting as early as
middle school; b) retaining the participant pool via remediation, support
services such as tutoring and financial aid, bridging programs, and
activities designed to motivate; and c) strengthening the participant pool
via acquisition of knowledge, academic enrichment and development of skills
deemed important for success as a scientist. The types of interventions
supported by the various programs have almost always included financial
support and encouragement to underrepresented minority undergraduate and
graduate students to participate in biomedical research in a variety of
academic institutions. Emphasis has also been placed on providing financial
support and encouragement directly to institutions themselves, with the
expectation they would use their enhanced capacity and resources to encourage
and sustain biomedical research among both faculty and students.
Some consistent beliefs underlying these interventions have been: 1) when
students are provided the opportunity to engage in state-of-the-art
biomedical research, with appropriate facilities, support and mentorship,
their appetite will be whetted to enter a career in biomedical research; and
2) once focused, they will show improvement in academic and other skills
needed to pursue successfully a biomedical research career. Based upon these
beliefs, one type of program component that has been supported is early
exposure to laboratory research and a research-experienced mentor.
Because these beliefs are consistent with the experience of many successful
scientists and make intuitive sense to many, diverse programmatic
interventions have evolved over the years. These include creation of intra-
institutional student-researcher environments, on- or off-campus summer
research experiences, attendance at professional scientific conferences and
research seminars, tutoring in "gate-keeper" courses (e.g., organic
chemistry, calculus), subsidy of GRE preparatory courses, post-baccalaureate
transitional research experiences (pre-graduate school), and individual
research fellowship support or training-grant-type support.
To date, however, the use of these interventions has been based more on
educated assumptions by the stakeholders than on systematic analysis. A
notable exception is the Merit Workshop at the University of California,
Berkeley, which grew out of Uri Treisman's observations of study behaviors of
at-risk students that challenged prevailing assumptions (1992, College
Mathematics Journal 23(5), 362-372). Nevertheless, there is a need for
research designed to develop an empirical base of evidence upon which new
interventions can be developed, and existing interventions can be improved.
The purpose of the present initiative is to invite innovative grant
applications that utilize research designed to identify and optimize
strategies for engaging students and characteristics of interventions (e.g.,
content and structure of program and curricula, methods, intensity, duration,
etc.) that encourage increased numbers of well-educated underrepresented
minority students to enter careers in mainstream biomedical research and be
competitive at the highest levels. It also invites applications for research
that would test underlying assumptions of how interventions interest,
challenge, motivate or otherwise affect students, especially regarding their
choice of a career in biomedical and/or behavioral research. Since the focus
of this RFA is on underrepresented minority students, proposed research
involving non-minority students should be comparative, rather than addressing
non-minority students exclusively.
Examples of some basic types of questions that might inform this purpose are:
Which characteristics of a student and program (e.g., skills, preparation)
are likely to lead to the pattern of persistent engagement that enables the
student to develop into a biomedical researcher? Which variables in a
student's background and/or personality are likely to affect career choice,
ability to excel and compete at the highest levels, and commitment to
succeed? In which ways do variables in student personality, attitude,
behavior, etc., influence the successful progression of career development?
Is there an optimum age or level of maturity of a student that maximizes
outcome? Are behavior patterns that are critical for a successful
biomedical/behavioral research career teachable? To what extent do the
teaching skills, preparedness, or motivation of one’s science teachers,
beginning in elementary school, impact one’s career development. To what
extent do peers, the immediate family, local community, and/or personal
economics influence minority individuals' choosing to enter or remain with
research careers? To what extent does the relative influence of these factors
vary across minority/ethnic groups, other subpopulation groups, or the
majority population? In which ways do (or could) various programs build on
these factors and/or serve as interventions to mediate their effect? Which
variables in interventions are likely to have the greatest effect on student
career choice? To what extent do mentors or other persons serving as role
models affect students' career choice? What are the most salient
characteristics of mentors and role models? How are these key factors
different and similar for each, and what different functions do mentors
versus role models versus social support from peers and/or family play in
affecting the success of minority researchers? At which developmental vs.
career stages do role models or mentors make a difference in students' career
choice? How does the relative effectiveness of different interventions change
with age/developmental stage? What is the relative efficacy of support to
institutions, individual investigators, and individual students? In which
ways does collaboration, particularly with majority institutions or
individuals, affect career choice among students who participate in training
or related programs addressed to minority institutions or individuals? To
what extent does the quality of the research infrastructure (environment,
facilities) impact career choice, in positive and/or negative ways?
It would be desirable if the proposed research would compare the
effectiveness (and potential cost-effectiveness) of the experimental
intervention(s) with that of existing practice. The efficacy of the
interventions should be considered in the context of the student
characteristics and the academic environment. Another desirable outcome would
be the revelation of new principles that would inform practice. Applicants
should discuss how recommendations based on the new evidence could be used to
modify and/or reinforce existing practices, and/or inform novel
interventions. Applicants should note that the proposed study should be a
research, rather than an evaluation, project. If development of a database
(e.g., problem-based, which is designed to address specific research
questions) is proposed, the rationale for selection of the specific elements
should be explained and justified.
This RFA will result in grants supporting individual and possibly multi-site
multidisciplinary research projects. It is expected that the research
findings will be published in peer-reviewed journals.
MECHANISM OF SUPPORT
This funding opportunity will use the NIH R01 award mechanism. As an
applicant, you will be solely responsible for planning, directing, and
executing the proposed project.
This funding opportunity uses just-in-time concepts. It also uses the modular
as well as the non-modular budget formats (see
http://grants.nih.gov/grants/funding/modular/modular.htm). Specifically, if
you are submitting an application with direct costs in each year of $250,000
or less, use the modular budget format described in the PHS 398 application
instructions. Otherwise follow the instructions for non-modular research
grant applications.
FUNDS AVAILABLE
The participating ICs intend to commit approximately $2.4 million in FY 05 to
fund six to eight new grants in response to this RFA. An applicant may
request a project period of up to four years and a budget for direct costs of
up to $300,000 per year. Because the nature and scope of the proposed
research will vary from application to application, it is anticipated that
the size and duration of each award will also vary. Although the financial
plans of the NIGMS provide support for this program, awards pursuant to this
RFA are contingent upon the availability of funds and the receipt of a
sufficient number of meritorious applications.
ELIGIBLE INSTITUTIONS
You may submit an application if your institution is a domestic one and has
any of the following characteristics:
o For-profit or non-profit organizations
o Public or private institutions, such as universities, colleges, hospitals,
and laboratories
o Units of State and local governments
o Eligible agencies of the Federal government
o Foreign institutions are not eligible to apply
o Faith-based or community-based organizations
INDIVIDUALS ELIGIBLE TO BECOME PRINCIPAL INVESTIGATORS
Any individual with the skills, knowledge, and resources necessary to carry
out the proposed research is invited to work with their institution to
develop an application for support. Individuals from underrepresented racial
and ethnic groups as well as individuals with disabilities are always
encouraged to apply for NIH programs.
WHERE TO SEND INQUIRIES
We encourage your inquiries concerning this RFA and welcome the opportunity
to answer questions from potential applicants. Inquiries may fall into three
areas: scientific/research, peer review, and financial or grants management
issues:
o Direct your questions about scientific/research issues to:
Clifton A. Poodry, Ph.D.
Director, Division of Minority Opportunities in Research
National Institute of General Medical Sciences, NIH
45 Center Drive, Suite 2AS.37, MSC 6200
Bethesda, MD 20892-6200
Telephone: (301) 594-3900
FAX: (301) 480-2753
E-mail: poodryc@nigms.nih.gov
Matthew A. Kinnard, Ph.D.
Director, Extramural Associates Program
National Institute of Child Health and Human Development
National Institutes of Health
6100 Executive Boulevard, Room 5E03, MSC 7510
Bethesda, MD 20892-7510
Telephone: (301) 435-2736
Fax: (301) 480-0393
Email: kinnardm@mail.nih.gov
o Direct your questions about peer review issues to:
Helen R. Sunshine, Ph.D.
Chief, Office of Scientific Review
National Institute of General Medical Sciences, NIH
45 Center Drive, Room 3AN.12, MSC 6200
Bethesda, Maryland 20892-6200
Telephone: (301) 594-2881
FAX: (301) 480-8506
E-mail: sunshinh@nigms.nih.gov
o Direct your questions about financial or grants management matters to:
Ms. Antoinette Holland
Grants Management Officer
National Institute of General Medical Sciences, NIH
45 Center Drive, Room 2AN.50, MSC 6200
Bethesda, MD 20892-6200
Telephone: (301) 594-5132
FAX: (301) 480-2554
E-mail: hollanda@nigms.nih.gov
LETTER OF INTENT
Prospective applicants are asked to submit a letter of intent that includes
the following information:
o Descriptive title of the proposed research
o Name, address, and telephone number of the Principal Investigator
o Names of other key personnel
o Participating institutions
o Number and title of this RFA
Although a letter of intent is not required, is not binding, and does not
enter into the review of a subsequent application, the information that it
contains allows IC staff to estimate the potential review workload and plan
the review.
The letter of intent is to be sent by the date listed at the beginning of
this document. The letter of intent should be sent to:
Clifton A. Poodry, Ph.D.
Director, Division of Minority Opportunities in Research
National Institute of General Medical Sciences, NIH
45 Center Drive, Suite 2AS.37, MSC 6200
Bethesda, MD 20892-6200
Telephone: (301) 594-3900
FAX: (301) 480-2753
E-mail: poodryc@nigms.nih.gov
SUBMITTING AN APPLICATION
Applications must be prepared using the PHS 398 research grant application
instructions and forms (rev. 5/2001). Applications must have a DUN and
Bradstreet (D&B) Data Universal Numbering System (DUNS) number as the
Universal Identifier when applying for Federal grants or cooperative
agreements. The D&B number can be obtained by calling (866) 705-5711 or
through the web site at http://www.dunandbradstreet.com/. The D&B number
should be entered on line 11 of the face page of the PHS 398 form. The PHS
398 document is available at
http://grants.nih.gov/grants/funding/phs398/phs398.html in an interactive
format. For further assistance contact GrantsInfo, Telephone (301) 710-0267,
Email: GrantsInfo@nih.gov.
SPECIFIC INSTRUCTIONS FOR MODULAR GRANT APPLICATIONS: Applications
requesting up to $250,000 per year in direct costs must be submitted in a
modular grant format. The modular grant format simplifies the preparation of
the budget in these applications by limiting the level of budgetary detail.
Applicants request direct costs in $25,000 modules. Section C of the
research grant application instructions for the PHS 398 (rev. 5/2001) at
http://grants.nih.gov/grants/funding/phs398/phs398.html includes step-by-step
guidance for preparing modular grants. Additional information on modular
grants is available at:
http://grants.nih.gov/grants/funding/modular/modular.htm.
USING THE RFA LABEL: The RFA label available in the PHS 398 (rev. 5/2001)
application form must be affixed to the bottom of the face page of the
application. Type the RFA number on the label. Failure to use this label
could result in delayed processing of the application such that it may not
reach the review committee in time for review. In addition, the RFA title
and number must be typed on line 2 of the face page of the application form
and the YES box must be marked. The RFA label is also available at
http://grants.nih.gov/grants/funding/phs398/label-bk.pdf.
SENDING AN APPLICATION TO THE NIH: Submit a signed, typewritten original of
the application, including the Checklist and Appendix, and three signed
photocopies (without appendices) in one package to:
Center for Scientific Review
National Institutes of Health
6701 Rockledge Drive, Room 1040, MSC 7710
Bethesda, MD 20892-7710
Bethesda, MD 20817 (for express/courier service)
At the time of submission, two additional copies of the application
plus five sets of any appendix material must be sent to:
Helen R. Sunshine, Ph.D.
Chief, Office of Scientific Review
National Institute of General Medical Sciences, NIH
45 Center Drive, Room 3AN.12, MSC 6200
Bethesda, Maryland 20892-6200
Telephone: (301) 594-2881
FAX: (301) 480-8506
E-mail: sunshinh@nigms.nih.gov
APPLICATION PROCESSING: Applications must be received on or before the
application receipt date listed in the heading of this RFA. If an application
is received after that date, it will be returned to the applicant without
review.
The NIH will not accept any application in response to this RFA that is
essentially the same as one currently pending initial review, unless the
applicant withdraws the pending application. However, when a previously
unfunded application, originally submitted as an investigator-initiated
application, is to be submitted in response to an RFA, it is to be prepared
as a NEW application. That is, the application for the RFA must not include
an Introduction describing the changes and improvements made, and the text
must not be marked to indicate the changes from the previous unfunded version
of the application.
Although there is no immediate acknowledgement of the receipt of an
application, applicants are generally notified of the review and funding
assignment within 8 weeks.
PEER REVIEW PROCESS
Upon receipt, applications will be reviewed for completeness by the CSR and
responsiveness by the NIGMS. Incomplete and/or non-responsive applications
will be returned to the applicant without further consideration.
Applications that are complete and responsive to the RFA will be evaluated
for scientific and technical merit by an appropriate peer review group
convened by the NIGMS in accordance with the review criteria stated below.
As part of the initial merit review, all applications will:
o Undergo a process in which only those applications deemed to have the
highest scientific merit, generally the top half of the applications under
review, will be discussed and assigned a priority score
o Receive a written critique
o Receive a second level review by the appropriate national advisory council
or board.
REVIEW CRITERIA
The goal of the research supported by the present NIH grant mechanism is to
inform evidence-based interventions that will increase the numbers of
underrepresented minority students who enter careers in mainstream biomedical
and behavioral research at a competitive level. In the written comments,
reviewers will be asked to discuss the following aspects of the application
in order to judge the likelihood that the proposed research will have an
impact on the pursuit of these goals. The scientific review group will
address and consider each of these criteria in assigning the application's
overall score, weighting them as appropriate for each application.
o Significance
o Approach
o Innovation
o Investigator
o Environment
The application does not need to be strong in all categories to be judged
likely to have major scientific impact and thus deserve a high priority
score. For example, an investigator may propose to carry out important work
that by its nature is not innovative but is essential to move a field
forward.
SIGNIFICANCE: Does the proposed research address an important problem? If the
aims of the application are achieved, what is the likelihood that novel
interventions can result that will increase the numbers of underrepresented
minority students who enter mainstream biomedical and/or behavioral research
careers at highly competitive levels? What will be the effect of the research
on the concepts or methods that drive this field?
APPROACH: Are the conceptual framework, rationale, design, methods, and
analyses adequately developed, well-integrated, and appropriate to the aims
of the project? Does the PI justify adequately the rationale for the selected
experimental interventions and the data to be collected, e.g., for database
construction? Does this proposal incorporate a rigorous research-based
experimental design? Is the pool of target students clearly identified and
adequate to provide meaningful information? Does the applicant acknowledge
potential problem areas and consider alternative tactics?
INNOVATION: Does the project employ novel concepts, approaches or methods?
Are the aims original and innovative? Does the project challenge existing
paradigms or develop new methodologies or technologies?
INVESTIGATOR: Is the investigator appropriately trained and well suited to
carry out this work? Is the work proposed appropriate to the experience level
of the principal investigator? If the proposal utilizes a research team, is
the team composition, the unique expertise of the different team members, and
their expected contributions to the project, adequately described and
justified?
ENVIRONMENT: Does the educational/scientific environment in which the work
will be done contribute to the probability of success? Does the proposed
research take advantage of unique features of the educational/scientific
environment or employ useful collaborative arrangements? Is there evidence of
institutional support?
ADDITIONAL REVIEW CRITERIA: In addition to the above criteria, the following
items will be considered in the determination of scientific merit and the
priority score:
PROTECTION OF HUMAN SUBJECTS FROM RESEARCH RISK: The involvement of human
subjects and protections from research risk relating to their participation
in the proposed research will be assessed. (See criteria included in the
section on Federal Citations, below.)
INCLUSION OF WOMEN, MINORITIES AND CHILDREN IN RESEARCH: The adequacy of
plans to include subjects from both genders, all racial and ethnic groups
(and subgroups), and children as appropriate for the scientific goals of the
research will be assessed. Plans for the recruitment and retention of
subjects will also be assessed. (See Inclusion Criteria in the sections on
Federal Citations, below.)
ADDITIONAL CONSIDERATIONS
DATA SHARING: A data sharing plan is not required.
BUDGET: The reasonableness of the proposed budget and the requested period of
support in relation to the proposed research.
RECEIPT AND REVIEW SCHEDULE
Letter of Intent Receipt Date: October 18, 2004
Application Receipt Date: November 15, 2004
Peer Review Date: February-March, 2005
Council Review: May, 2005
Earliest Anticipated Start Date: July 1, 2005
AWARD CRITERIA
Award criteria that will be used to make award decisions include:
o Scientific merit (as determined by peer review)
o Availability of funds
o Programmatic priorities
REQUIRED FEDERAL CITATIONS
HUMAN SUBJECTS PROTECTION: Federal regulations (45CFR46) require that
applications and proposals involving human subjects must be evaluated with
reference to the risks to the subjects, the adequacy of protection against
these risks, the potential benefits of the research to the subjects and
others, and the importance of the knowledge gained or to be gained.
http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm
INCLUSION OF WOMEN AND MINORITIES IN CLINICAL RESEARCH: It is the policy of
the NIH that women and members of minority groups and their sub-populations
must be included in all NIH-supported clinical research projects unless a
clear and compelling justification is provided indicating that inclusion is
inappropriate with respect to the health of the subjects or the purpose of
the research. This policy results from the NIH Revitalization Act of 1993
(Section 492B of Public Law 103-43).
All investigators proposing clinical research should read the "NIH Guidelines
for Inclusion of Women and Minorities as Subjects in Clinical Research -
Amended, October, 2001," published in the NIH Guide for Grants and Contracts
on October 9, 2001
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-001.html
a complete copy of the updated Guidelines are available at
http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm.
The amended policy incorporates: the use of an NIH definition of clinical
research; updated racial and ethnic categories in compliance with the new OMB
standards; clarification of language governing NIH-defined Phase III clinical
trials consistent with the new PHS Form 398; and updated roles and
responsibilities of NIH staff and the extramural community. The policy
continues to require for all NIH-defined Phase III clinical trials that: a)
all applications or proposals and/or protocols must provide a description of
plans to conduct analyses, as appropriate, to address differences by
sex/gender and/or racial/ethnic groups, including subgroups if applicable;
and b) investigators must report annual accrual and progress in conducting
analyses, as appropriate, by sex/gender and/or racial/ethnic group
differences.
INCLUSION OF CHILDREN AS PARTICIPANTS IN RESEARCH INVOLVING HUMAN SUBJECTS:
The NIH maintains a policy that children (i.e., individuals under the age of
21) must be included in all human subjects research, conducted or supported
by the NIH, unless there are scientific and ethical reasons not to include
them.
All investigators proposing research involving human subjects should read the
"NIH Policy and Guidelines" on the inclusion of children as participants in
research involving human subjects that is available at
http://grants.nih.gov/grants/funding/children/children.htm
REQUIRED EDUCATION ON THE PROTECTION OF HUMAN SUBJECT PARTICIPANTS: NIH
policy requires education on the protection of human subject participants for
all investigators submitting NIH proposals for research involving human
subjects. You will find this policy announcement in the NIH Guide for Grants
and Contracts Announcement, dated June 5, 2000, at
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-039.html.
PUBLIC ACCESS TO RESEARCH DATA THROUGH THE FREEDOM OF INFORMATION ACT: The
Office of Management and Budget (OMB) Circular A-110 has been revised to
provide public access to research data through the Freedom of Information Act
(FOIA) under some circumstances. Data that are (1) first produced in a
project that is supported in whole or in part with Federal funds and (2)
cited publicly and officially by a Federal agency in support of an action
that has the force and effect of law (i.e., a regulation) may be accessed
through FOIA. It is important for applicants to understand the basic scope
of this amendment. NIH has provided guidance at
http://grants.nih.gov/grants/policy/a110/a110_guidance_dec1999.htm.
Applicants may wish to place data collected under this RFA in a public
archive, which can provide protections for the data and manage the
distribution for an indefinite period of time. If so, the application should
include a description of the archiving plan in the study design and include
information about this in the budget justification section of the
application. In addition, applicants should think about how to structure
informed consent statements and other human subjects procedures given the
potential for wider use of data collected under this award.
STANDARDS FOR PRIVACY OF INDIVIDUALLY IDENTIFIABLE HEALTH INFORMATION: The
Department of Health and Human Services (DHHS) issued final modification to
the "Standards for Privacy of Individually Identifiable Health Information",
the "Privacy Rule," on August 14, 2002. The Privacy Rule is a federal
regulation under the Health Insurance Portability and Accountability Act
(HIPAA) of 1996 that governs the protection of individually identifiable
health information, and is administered and enforced by the DHHS Office for
Civil Rights (OCR).
Decisions about applicability and implementation of the Privacy Rule reside
with the researcher and his/her institution. The OCR website
http://www.hhs.gov/ocr/ provides information on the Privacy Rule, including a
complete Regulation Text and a set of decision tools on "Am I a covered
entity?" Information on the impact of the HIPAA Privacy Rule on NIH
processes involving the review, funding, and progress monitoring of grants,
cooperative agreements, and research contracts can be found at
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-025.html.
URLs IN NIH GRANT APPLICATIONS OR APPENDICES: All applications and proposals
for NIH funding must be self-contained within specified page limitations.
Unless otherwise specified in an NIH solicitation, Internet addresses (URLs)
should not be used to provide information necessary to the review because
reviewers are under no obligation to view the Internet sites. Furthermore,
we caution reviewers that their anonymity may be compromised when they
directly access an Internet site.
HEALTHY PEOPLE 2010: The Public Health Service (PHS) is committed to
achieving the health promotion and disease prevention objectives of "Healthy
People 2010," a PHS-led national activity for setting priority areas. This
RFA is related to one or more of the priority areas. Potential applicants may
obtain a copy of "Healthy People 2010" at
http://www.health.gov/healthypeople.
AUTHORITY AND REGULATIONS: This program is described in the Catalog of
Federal Domestic Assistance at http://www.cfda.gov/ and is not subject to the
intergovernmental review requirements of Executive Order 12372 or Health
Systems Agency review. Awards are made under the authorization of Sections
301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284)
and under Federal Regulations 42 CFR 52 and 45 CFR Parts 74 and 92. All
awards are subject to the terms and conditions, cost principles, and other
considerations described in the NIH Grants Policy Statement. The NIH Grants
Policy Statement can be found at
http://grants.nih.gov/grants/policy/policy.htm
The PHS strongly encourages all grant recipients to provide a smoke-free
workplace and discourage the use of all tobacco products. In addition,
Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in
certain facilities (or in some cases, any portion of a facility) in which
regular or routine education, library, day care, health care, or early
childhood development services are provided to children. This is consistent
with the PHS mission to protect and advance the physical and mental health of
the American people.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
|
|
|
Department of Health and Human Services (HHS)
|
|
|
|
NIH... Turning Discovery Into Health®
|